: Most-Cited Full-Text Articles http://dvd.sagepub.com/ Most-cited rankings are recalculated at the beginning of the month and are based on citations to articles on this journal site from articles in other HighWire-hosted journals. 2009-11-08 <![CDATA[Pathophysiology of erectile dysfunction]]> http://dvd.sagepub.com/cgi/content/short/2/4/272?rss=1&ssource=mfc Jul 1, 2002; 2:272-276
Article]]> Ian Eardley 2002-07-01 10.1177/14746514020020040701 SAGE Publications <![CDATA[The Alphabet Strategy: The ABC of reducing diabetes complications]]> http://dvd.sagepub.com/cgi/content/short/2/1/58?rss=1&ssource=mfc Jan 1, 2002; 2:58-59
Article]]> Vinod Patel, John Morrissey 2002-01-01 10.1177/14746514020020010701 SAGE Publications <![CDATA[The Diabetes Prevention Program: headline results]]> http://dvd.sagepub.com/cgi/content/short/1/1/62?rss=1&ssource=mfc Aug 1, 2001; 1:62-64
Article]]> Clifford J Bailey 2001-08-01 10.1177/14746514010010011001 SAGE Publications <![CDATA[The rising tide of type 2 diabetes]]> http://dvd.sagepub.com/cgi/content/short/1/1/37?rss=1&ssource=mfc Aug 1, 2001; 1:37-43
Article]]> Caroline Day 2001-08-01 10.1177/14746514010010010601 SAGE Publications <![CDATA[From 4S to FIELD and PROactive: 10 years of CV trials in people with diabetes]]> http://dvd.sagepub.com/cgi/content/short/5/4/218?rss=1&ssource=mfc Jul 1, 2005; 5:218-225
Article]]> Roland W Mccallum, Miles Fisher 2005-07-01 10.1177/14746514050050040701 SAGE Publications <![CDATA[Review: Use of nicotinic acid in patients with elevated fasting glucose, diabetes, or metabolic syndrome]]> http://dvd.sagepub.com/cgi/content/short/4/2/78?rss=1&ssource=mfc Mar 1, 2004; 4:78-85
Article]]> Mark E Mcgovern 2004-03-01 10.1177/14746514040040020301 SAGE Publications <![CDATA[Managing care of type 2 diabetes. Learnings from T2ARDIS]]> http://dvd.sagepub.com/cgi/content/short/1/1/68?rss=1&ssource=mfc Aug 1, 2001; 1:68-72
Article]]> Julia M Bottomley, T2ARDIS Steering Committee and UK Centres 2001-08-01 10.1177/14746514010010011201 SAGE Publications <![CDATA[The silent sextet]]> http://dvd.sagepub.com/cgi/content/short/1/1/3?rss=1&ssource=mfc Aug 1, 2001; 1:3-6
Article]]> Ian W Campbell, Henry Purcell 2001-08-01 10.1177/14746514010010010101 SAGE Publications <![CDATA[Review: Early-onset type 2 diabetes mellitus: a condition with elevated cardiovascular risk?]]> http://dvd.sagepub.com/cgi/content/short/8/2/61?rss=1&ssource=mfc Mar 1, 2008; 8:61-65
Article]]> Soon H Song 2008-03-01 10.1177/14746514080080020201 SAGE Publications <![CDATA[Review: Managing cardiovascular risk in patients with diabetes]]> http://dvd.sagepub.com/cgi/content/short/5/6/325?rss=1&ssource=mfc Nov 1, 2005; 5:325-329
Article]]> Richard Donnelly 2005-11-01 10.1177/14746514050050060501 SAGE Publications <![CDATA[The Alphabet strategy -- a tool to achieve clinical trial standards in routine practice?]]> http://dvd.sagepub.com/cgi/content/short/3/6/410?rss=1&ssource=mfc Nov 1, 2003; 3:410-413
Article]]> Pachaiappan Jaiveer, Jaiveer Saraswathy, James D Lee, John Morrissey, Vinod Patel 2003-11-01 10.1177/14746514030030060401 SAGE Publications <![CDATA[Hypertension, diabetes and cardiovascular risk in ethnic minorities in the UK]]> http://dvd.sagepub.com/cgi/content/short/3/4/286?rss=1&ssource=mfc Jul 1, 2003; 3:286-293
Article]]> Francesco P Cappuccio, Antonio Barbato, Sally M Kerry 2003-07-01 10.1177/14746514030030041101 SAGE Publications <![CDATA[Insulin resistance, haemostatic factors and cardiovascular risk]]> http://dvd.sagepub.com/cgi/content/short/2/1/19?rss=1&ssource=mfc Jan 1, 2002; 2:19-26
Article]]> Joseph D Mills, Peter J Grant 2002-01-01 10.1177/14746514020020011301 SAGE Publications <![CDATA[Review: Male obesity and reproductive potential]]> http://dvd.sagepub.com/cgi/content/short/9/1/7?rss=1&ssource=mfc Jan 1, 2009; 9:7-12
Article]]> A. Ghiyath Shayeb, Siladitya Bhattacharya 2009-01-01 10.1177/1474651408101281 SAGE Publications <![CDATA[Paradoxical decrease in high density lipoprotein-cholesterol associated with statin and fenofibrate combination therapy]]> http://dvd.sagepub.com/cgi/content/short/7/6/295?rss=1&ssource=mfc Nov 1, 2007; 7:295-297
Article]]> Jennifer Glaysher, Charles Van Heyningen 2007-11-01 10.1177/14746514070070060701 SAGE Publications <![CDATA[Review: Inhaled insulin: overcoming barriers to insulin therapy?]]> http://dvd.sagepub.com/cgi/content/short/6/3/103?rss=1&ssource=mfc May 1, 2006; 6:103-108
Article]]> Srikanth Bellary, Anthony H Barnett 2006-05-01 10.1177/14746514060060030201 SAGE Publications <![CDATA[Metformin inhibits monocyte adhesion to endothelial cells and foam cell formation]]> http://dvd.sagepub.com/cgi/content/short/3/4/302?rss=1&ssource=mfc Jul 1, 2003; 3:302-310
Article]]> Jean-Claude Mamputu, Nicolas Wiernsperger, Genevieve Renier 2003-07-01 10.1177/14746514030030041501 SAGE Publications <![CDATA[Review: Modern treatment of erectile dysfunction]]> http://dvd.sagepub.com/cgi/content/short/2/4/255?rss=1&ssource=mfc Jul 1, 2002; 2:255-261
Article]]> Waleed Ali, Dler Besarani, Roger Kirby 2002-07-01 10.1177/14746514020020040301 SAGE Publications <![CDATA[Angiotensin II receptor blockade and type 2 diabetic nephropathy]]> http://dvd.sagepub.com/cgi/content/short/2/2/101?rss=1&ssource=mfc Mar 1, 2002; 2:101-105
Article]]> Rudy W Bilous 2002-03-01 10.1177/14746514020020020701 SAGE Publications <![CDATA[Prospective evaluation of diabetic ischaemic heart disease by computed tomography: the PREDICT study]]> http://dvd.sagepub.com/cgi/content/short/2/1/69?rss=1&ssource=mfc Jan 1, 2002; 2:69-72
Article]]> Robert S Elkeles, Marcus Flather, Michael D Feher, Ian Godsland, William Richmond, Stephen E Humphries, Michael B Rubens, S Richard Underwood 2002-01-01 10.1177/14746514020020011001 SAGE Publications <![CDATA[Scottish Intercollegiate Guidelines Network: management of diabetes (SIGN 55)]]> http://dvd.sagepub.com/cgi/content/short/2/1/50?rss=1&ssource=mfc Jan 1, 2002; 2:50-52
Article]]> Ian W Campbell, Moray Nairn 2002-01-01 10.1177/14746514020020010501 SAGE Publications <![CDATA[Review: Adipose tissue: passive sump or active pump?]]> http://dvd.sagepub.com/cgi/content/short/1/2/110?rss=1&ssource=mfc Nov 1, 2001; 1:110-114
Article]]> Colin Perry, Naveed Sattar, John Petrie 2001-11-01 10.1177/14746514010010020801 SAGE Publications <![CDATA[Review: Optimal dosing strategies for maximising the clinical response to metformin in type 2 diabetes]]> http://dvd.sagepub.com/cgi/content/short/1/1/28?rss=1&ssource=mfc Aug 1, 2001; 1:28-36
Article]]> John Hb Scarpello 2001-08-01 10.1177/14746514010010010501 SAGE Publications <![CDATA[Clinical aspects of silent myocardial ischaemia: with particular reference to diabetes mellitus]]> http://dvd.sagepub.com/cgi/content/short/9/3/110?rss=1&ssource=mfc May 1, 2009; 9:110-116
Article]]> Marc Dweck, Ian W Campbell, Douglas Miller, C Mark Francis 2009-05-01 10.1177/1474651409105249 SAGE Publications <![CDATA[Placental dysfunction and stillbirth in gestational diabetes mellitus]]> http://dvd.sagepub.com/cgi/content/short/9/1/38?rss=1&ssource=mfc Jan 1, 2009; 9:38-40
Article]]> Ian W Campbell, Catriona Duncan, Rennie Urquhart, Margaret Evans 2009-01-01 10.1177/1474651408101348 SAGE Publications <![CDATA[Review: Obesity and pregnancy: an obstetrician's view]]> http://dvd.sagepub.com/cgi/content/short/9/1/19?rss=1&ssource=mfc Jan 1, 2009; 9:19-22
Article]]> Tahir A Mahmood 2009-01-01 10.1177/1474651408101278 SAGE Publications <![CDATA[Will the NICE guidelines on diabetes in pregnancy improve outcomes?]]> http://dvd.sagepub.com/cgi/content/short/8/3/107?rss=1&ssource=mfc May 1, 2008; 8:107-110
Article]]> Anne Dornhorst 2008-05-01 10.1177/14746514080080030101 SAGE Publications <![CDATA[Review: 50 years later: is metformin a vascular drug with antidiabetic properties?]]> http://dvd.sagepub.com/cgi/content/short/7/5/204?rss=1&ssource=mfc Sep 1, 2007; 7:204-210
Article]]> Nicolas F Wiernsperger 2007-09-01 10.1177/14746514070070050201 SAGE Publications <![CDATA[Review: Inhibition of dipeptidyl peptidase-4 with vildagliptin: a potential new treatment for type 2 diabetes]]> http://dvd.sagepub.com/cgi/content/short/6/4/150?rss=1&ssource=mfc Jul 1, 2006; 6:150-156
Article]]> Richard E Pratley, Afshin Salsali, Glenn Matfin 2006-07-01 10.1177/14746514060060040201 SAGE Publications <![CDATA[Goodbye glitazars?]]> http://dvd.sagepub.com/cgi/content/short/6/3/135?rss=1&ssource=mfc May 1, 2006; 6:135-137
Article]]> Deane Conlon 2006-05-01 10.1177/14746514060060030601 SAGE Publications <![CDATA[Review: Pharmacological approaches to reduce adiposity]]> http://dvd.sagepub.com/cgi/content/short/6/3/121?rss=1&ssource=mfc May 1, 2006; 6:121-125
Article]]> Caroline Day, Clifford J Bailey 2006-05-01 10.1177/14746514060060030401 SAGE Publications <![CDATA[Treating resistant hypertension in type 2 diabetes: a role for spironolactone?]]> http://dvd.sagepub.com/cgi/content/short/6/2/90?rss=1&ssource=mfc Mar 1, 2006; 6:90-92
Article]]> Adrian G Stanley, Philip Swales, Herbert Thurston, Bryan Williams 2006-03-01 10.1177/14746514060060020701 SAGE Publications <![CDATA[AUDIT study. Evidence of global undertreatment of dyslipidaemia in patients with type 2 diabetes mellitus]]> http://dvd.sagepub.com/cgi/content/short/6/1/31?rss=1&ssource=mfc Jan 1, 2006; 6:31-40
Article]]> Lawrence A Leiter, D John Betteridge, Antonio R Chacra, Alan Chait, Eleuterio Ferrannini, Steven M Haffner, Takashi Kadowaki, Jaakko Tuomilehto, Paul Zimmet, Connie B Newman, Judith Hey-Hadavi, Caroline Walkinshaw, On Behalf Of The Audit Study Steering Committee 2006-01-01 10.1177/14746514060060010401 SAGE Publications <![CDATA[Fenofibrate in type 2 diabetes: The FIELD study: Fibrate Intervention and Event Lowering in Diabetes (FIELD)]]> http://dvd.sagepub.com/cgi/content/short/5/6/330?rss=1&ssource=mfc Nov 1, 2005; 5:330-333
Article]]> Michael D Feher, Robert S Elkeles 2005-11-01 10.1177/14746514050050060601 SAGE Publications <![CDATA[Review: Blood pressure reduction in the metabolic syndrome and type 2 diabetes: current concepts]]> http://dvd.sagepub.com/cgi/content/short/5/6/320?rss=1&ssource=mfc Nov 1, 2005; 5:320-324
Article]]> Michael Schachter 2005-11-01 10.1177/14746514050050060401 SAGE Publications <![CDATA[Review: Cardiovascular risk assessment in the metabolic syndrome, screening for subclinical disease, and implications for treatment]]> http://dvd.sagepub.com/cgi/content/short/5/6/305?rss=1&ssource=mfc Nov 1, 2005; 5:305-313
Article]]> Nathan D Wong 2005-11-01 10.1177/14746514050050060201 SAGE Publications <![CDATA[Tight glycaemic control: the key to improving the management of type 2 diabetes]]> http://dvd.sagepub.com/cgi/content/short/5/4/184?rss=1&ssource=mfc Jul 1, 2005; 5:184-185
Article]]> George Alberti 2005-07-01 10.1177/14746514050050040101 SAGE Publications <![CDATA[Comparison of three different definitions for the metabolic syndrome in non-diabetic Europeans]]> http://dvd.sagepub.com/cgi/content/short/5/3/161?rss=1&ssource=mfc May 1, 2005; 5:161-168
Article]]> THE DECODE STUDY GROUP, Qing Qiao 2005-05-01 10.1177/14746514050050030901 SAGE Publications <![CDATA[Amylin analogue as an antidiabetic agent]]> http://dvd.sagepub.com/cgi/content/short/5/3/151?rss=1&ssource=mfc May 1, 2005; 5:151-154
Article]]> Caroline Day 2005-05-01 10.1177/14746514050050030701 SAGE Publications <![CDATA[Review: Development and therapeutic potential of incretin hormone analogues for type 2 diabetes]]> http://dvd.sagepub.com/cgi/content/short/5/3/134?rss=1&ssource=mfc May 1, 2005; 5:134-140
Article]]> Brian D Green, Nigel Irwin, Victor A Gault, Finbarr Pm O''Harte, Peter R Flatt 2005-05-01 10.1177/14746514050050030401 SAGE Publications <![CDATA[Review: The endocannabinoid system: a new therapeutic target for cardiovascular risk factor management]]> http://dvd.sagepub.com/cgi/content/short/5/3/121?rss=1&ssource=mfc May 1, 2005; 5:121-124
Article]]> Nick Finer, Uberto Pagotto 2005-05-01 10.1177/14746514050050030201 SAGE Publications <![CDATA[NSF for Diabetes, update -- year two]]> http://dvd.sagepub.com/cgi/content/short/5/2/103?rss=1&ssource=mfc Mar 1, 2005; 5:103-105
Article]]> Caroline Day 2005-03-01 10.1177/14746514050050020901 SAGE Publications <![CDATA[Review: Current status of the development of inhaled insulin]]> http://dvd.sagepub.com/cgi/content/short/4/5/295?rss=1&ssource=mfc Sep 1, 2004; 4:295-301
Article]]> Lutz Heinemann, Tim Heise 2004-09-01 10.1177/14746514040040050201 SAGE Publications <![CDATA[New prolonged-release metformin improves gastrointestinal tolerability]]> http://dvd.sagepub.com/cgi/content/short/4/4/273?rss=1&ssource=mfc Jul 1, 2004; 4:273-277
Article]]> Jaime Davidson, Harry Howlett 2004-07-01 10.1177/14746514040040041101 SAGE Publications <![CDATA[Review: When should bariatric surgery be used in the treatment of type 2 diabetes?]]> http://dvd.sagepub.com/cgi/content/short/4/4/232?rss=1&ssource=mfc Jul 1, 2004; 4:232-237
Article]]> Jonathan Pinkney, David Kerrigan 2004-07-01 10.1177/14746514040040040301 SAGE Publications <![CDATA[Reclassifying insulins]]> http://dvd.sagepub.com/cgi/content/short/4/1/39?rss=1&ssource=mfc Jan 1, 2004; 4:39-42
Article]]> Michael D Feher, Clifford J Bailey 2004-01-01 10.1177/14746514040040010701 SAGE Publications <![CDATA[Insulin]]> http://dvd.sagepub.com/cgi/content/short/4/1/5?rss=1&ssource=mfc Jan 1, 2004; 4:5-8
Article]]> Jonathan Levy 2004-01-01 10.1177/14746514040040010101 SAGE Publications <![CDATA[ASCOT -- lipid lowering arm]]> http://dvd.sagepub.com/cgi/content/short/3/3/200?rss=1&ssource=mfc May 1, 2003; 3:200-201
Article]]> Mike Kirby 2003-05-01 10.1177/14746514030030030701 SAGE Publications <![CDATA[Infections in the diabetic foot: A practical management guide to foot care]]> http://dvd.sagepub.com/cgi/content/short/3/2/132?rss=1&ssource=mfc Mar 1, 2003; 3:132-136
Article]]> Neil Munro, Nicole Rich, Colin McIntosh, Ali VM Foster, Michael E Edmonds 2003-03-01 10.1177/14746514030030020901 SAGE Publications <![CDATA[The problem of polypharmacy in type 2 diabetes]]> http://dvd.sagepub.com/cgi/content/short/3/1/54?rss=1&ssource=mfc Jan 1, 2003; 3:54-56
Article]]> Alistair Emslie-Smith, Jon Dowall, Andrew Morris 2003-01-01 10.1177/14746514030030010901 SAGE Publications